Edward Crisileo v. HHS - Tdap, Guillain-Barré Syndrome (GBS) (2020)

Edward Crisileo filed a petition on September 7, 2018, seeking compensation under the National Vaccine Injury Compensation Program. He alleged that he developed Guillain-Barré Syndrome (GBS) as a result of a Tetanus-diphtheria-acellular pertussis (Tdap) vaccination he received on September 13, 2015.

The respondent, the Secretary of Health and Human Services, denied that the Tdap vaccine caused Mr. Crisileo's GBS or its residual effects.

Despite maintaining their positions, both parties agreed to settle the case. A joint stipulation was filed on June 3, 2020, agreeing that the issues could be resolved through settlement and that a decision should be entered awarding compensation.

The court reviewed the stipulation and found it reasonable, adopting it as its decision. The stipulation awarded Mr.

Crisileo a lump sum of $77,500.00 as compensation for all damages available under the program. The decision was issued on July 8, 2020.